1. Researcher's Perceptions on Publishing 'negative' Results and Open Access
- Author
-
Alberto Malerba, Virginia Arechavala-Gomeza, Lucía Echevarría, Handicap neuromusculaire : Physiopathologie, Biothérapie et Pharmacologies appliquées (END-ICAP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Royal Holloway [University of London] (RHUL), Biocruces Bizkaia Health Research Institute [Baracaldo], Fundación Ikerbasque [Bilbao], European Commission, EC: CA1703 European Cooperation in Science and Technology, COST Ikerbasque, Basque Foundation for Science Instituto de Salud Carlos III, ISCIII: CPII17/00004 European Regional Development Fund, ERDF, All authors are members of COST Action DARTER, which is funded by the EU (grant code CA1703, October 2018-October 2022), V.A.-G. holds a Miguel Servet Fellowship from the ISCIII (CPII17/00004), part-funded by ERDF/FEDER., All authors are members of COST Action DARTER, which is funded by the EU (grant code CA1703, October 2018–October 2022), V.A.-G. acknowledges funding from Ikerbasque (Basque Foundation for Science)., Ikerbasque - Basque Foundation for Science, and HAL UVSQ, Équipe
- Subjects
0301 basic medicine ,Value (ethics) ,Open science ,[SDV]Life Sciences [q-bio] ,Brief Communication ,Biochemistry ,Access to Information ,03 medical and health sciences ,0302 clinical medicine ,Open Science ,Drug Discovery ,Genetics ,Molecular Biology ,Publication ,open access ,business.industry ,Reproducibility of Results ,null hypothesis ,Subject (documents) ,Public relations ,3. Good health ,[SDV] Life Sciences [q-bio] ,science policy ,030104 developmental biology ,Publishing ,Open Access Publishing ,030220 oncology & carcinogenesis ,Molecular Medicine ,Science policy ,negative results ,Paywall ,business ,Psychology ,Null hypothesis - Abstract
International audience; Scientific advance is based on reproducibility, corroboration, and availability of research results. However, large numbers of experimental results that contradict previous work do not get published and many research results are not freely available as they are hidden behind paywalls. As part of COST Action "DARTER", a network of researchers in the field of RNA therapeutics, we have performed a small survey among our members and their colleagues to assess their opinion on the subject of publishing contradictory or ambiguous results and their attitude to open access (OA) publishing. Our survey indicates that, although researchers highly value publication of "negative"results, they often do not publish their own, citing lack of time and the perception that those results may not be as highly cited. OA, on the other hand, seems to be widely accepted, but in many cases not actively sought by researchers due to higher costs associated with it.
- Published
- 2021